Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alliance Pharma PLC (GB:APH)
LSE:APH
Holding GB:APH?
Track your performance easily
APH Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range24.55p - 50.40p
Previous Close38.6p
Volume1.28M
Average Volume (3M)2.10M
Market Cap
£198.93M
Enterprise Value304.79M
Total Cash (Recent Filing)£31.71M
Total Debt (Recent Filing)£137.58M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Sep 24, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 22, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding540,565,539
10 Day Avg. Volume819,090
30 Day Avg. Volume2,098,828
Standard Deviation0.10
R-Squared0.11
Alpha-0.00563
Financial Highlights & Ratios
Price to Book (P/B)-1.57
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)6.80
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
65.67pPrice Target Upside70.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Alliance Pharma News
PremiumCompany Announcements
Alliance Pharma Confronts AGM Dissent
PremiumCompany Announcements
Alliance Pharma Sustains Growth Amidst Challenges
PremiumCompany Announcements
Slater Investments Boosts Stake in Alliance Pharma
PremiumCompany Announcements
Alliance Pharma Stake Shifts with Slater Investments
PremiumCompany Announcements
Slater Investments Ups Stake in Alliance Pharma
PremiumCompany Announcements
Alliance Pharma Streamlines Management Team
PremiumCompany Announcements
Alliance Pharma Announces AGM and Growth Strategy
PremiumCompany Announcements
Alliance Pharma Reports Total Voting RightsOptions Prices
Currently, No data available
---
Ownership Overview
11.23% Insiders
4.83% Mutual Funds
0.06% Other Institutional Investors
83.88% Public Companies and
Individual Investors
APH FAQ
What was Alliance Pharma PLC’s price range in the past 12 months?
Alliance Pharma PLC lowest share price was 24.55p and its highest was 50.40p in the past 12 months.
What is Alliance Pharma PLC’s market cap?
Currently, no data Available
When is Alliance Pharma PLC’s upcoming earnings report date?
Alliance Pharma PLC’s upcoming earnings report date is Sep 24, 2024 which is in 16 days.
How were Alliance Pharma PLC’s earnings last quarter?
Alliance Pharma PLC released its earnings results on Jun 19, 2024. The company reported -0.071p earnings per share for the quarter, missing the consensus estimate of 0.029p by -0.1p.
Is Alliance Pharma PLC overvalued?
According to Wall Street analysts Alliance Pharma PLC’s price is currently Undervalued.
Does Alliance Pharma PLC pay dividends?
Alliance Pharma PLC pays a Annually dividend of 1.18p which represents an annual dividend yield of N/A. See more information on Alliance Pharma PLC dividends here
What is Alliance Pharma PLC’s EPS estimate?
Alliance Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alliance Pharma PLC have?
Alliance Pharma PLC has 540,565,550 shares outstanding.
What happened to Alliance Pharma PLC’s price movement after its last earnings report?
Alliance Pharma PLC reported an EPS of -0.071p in its last earnings report, missing expectations of 0.029p. Following the earnings report the stock price went up 12.676%.
Which hedge fund is a major shareholder of Alliance Pharma PLC?
Currently, no hedge funds are holding shares in GB:APH
---
Alliance Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.78%
12-Months-Change
Fundamentals
Return on Equity
-13.11%
Trailing 12-Months
Asset Growth
-22.79%
Trailing 12-Months
Company Description
Alliance Pharma PLC
Alliance Pharma PLC is a player in the healthcare market. The company's business includes acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol.
---
APH Stock 12 Month Forecast
Average Price Target
65.67p
▲(70.13% Upside)
Technical Analysis
Advanced Medical Solutions
―
Hikma Pharmaceuticals
―
Scancell Holdings
―
Eco Animal Health
―
Best Analysts Covering APH
1 Year
1 Year Success Rate
2/13 ratings generated profit
1 Year Average Return
-27.99%
assigned a buy rating 7 months ago
Copying Charles Weston's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -27.99% per trade.
---